Observational studyFrontiers in immunology2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.
Giulia Salvatore et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.